The Population Research Core (PopRC) is a new shared resource for the HCCC. The Population Research Core is designed to assist HCCC members in conducting the highest quality genetic, epidemiologic, behavioral, applied, and surveillance cancer research based on enhancing access to, and connection between, large population databases. Its basic function is to serve as a resource to HCCC investigators who want to extend research findings to specific populations and who want to explore other population-based research questions. More specifically, the Population Research Core provides access for HCCC to: ? lowa Cancer Registry surveillance data ? lowa and SEER tissue repositories ? lowa mortality database ? lowa voter registration database ? lowa driver's license database ? SEER-Medicare database ? lowa Medicaid Database ? Cancer Care Outcomes Research &Surveillance Consortium ? Health Effectiveness Research Center ? Agricultural Health Study ? Center for the Heatth Effects of Environmental Contamination ? lowa Cancer Consortium The Population Research Core includes staff based in institutional centers of expertise, with intimate knowledge of the resources of these centers and how to harness them. Despite being a new shared research resource, in 2009, the Population Research Core provided services to 18 HCCC members with peer reviewed funding including investigators who are members of all 6 programs.

Public Health Relevance

The ability to analyze large population-based databases, and equally importantly, link them to each other, is vital for many cancer researchers. The Population Research Core provides access to such data to cancer researchers, and also provides the expertise needed to utilize this data which would, otherwise, not be available.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-14
Application #
8640104
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
14
Fiscal Year
2014
Total Cost
$79,165
Indirect Cost
$28,740
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Lee, Jennifer E; Anderson, Carryn M; Perkhounkova, Yelena et al. (2018) Transcutaneous Electrical Nerve Stimulation Reduces Resting Pain in Head and Neck Cancer Patients: A Randomized and Placebo-Controlled Double-Blind Pilot Study. Cancer Nurs :
McAtee, Caitlin O; Booth, Christine; Elowsky, Christian et al. (2018) Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling. Matrix Biol :
Leelakanok, Nattawut; Geary, Sean M; Salem, Aliasger K (2018) Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets. J Pharm Sci 107:690-697
Sperduto, Paul W; Deegan, Brian J; Li, Jing et al. (2018) Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases. Int J Radiat Oncol Biol Phys 101:845-853
Nagaraja, Archana S; Dood, Robert L; Armaiz-Pena, Guillermo et al. (2018) Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. JCI Insight 3:
Smith, Sonali M; Godfrey, James; Ahn, Kwang Woo et al. (2018) Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure. Cancer 124:2541-2551
Abarca, Tyler; Gao, Yubo; Monga, Varun et al. (2018) Improved survival for extremity soft tissue sarcoma treated in high-volume facilities. J Surg Oncol 117:1479-1486
Brogden, Kim A; Parashar, Deepak; Hallier, Andrea R et al. (2018) Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy. BMC Cancer 18:225
Do, Anh-Vu; Worthington, Kristan S; Tucker, Budd A et al. (2018) Controlled drug delivery from 3D printed two-photon polymerized poly(ethylene glycol) dimethacrylate devices. Int J Pharm 552:217-224
O'Leary, Brianne R; Houwen, Frederick K; Johnson, Chase L et al. (2018) Pharmacological Ascorbate as an Adjuvant for Enhancing Radiation-Chemotherapy Responses in Gastric Adenocarcinoma. Radiat Res 189:456-465

Showing the most recent 10 out of 1080 publications